Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * able to provide written informed consent * males or females. aged ≥ 18 years old * body mass index (bmi) between 18.0 and 26.0 kg/m2 * normal or abnormal but non-clinical significant physical examination, vital signs, 12-ecg and chest ct, etc * no plan of pregnancy and being willing to use effective contraceptive measures (including partner) from informed consent to 6 months after administration of scta01/placebo (abstinence,sterilization operation,contraceptive barrier,acyeterion , etc.)

inclusion criteria: * able to provide written informed consent * males or females. aged ≥ 18 years old * body mass index (bmi) between 18.0 and 26.0 kg/m2 * normal or abnormal but non-clinical significant physical examination, vital signs, 12-ecg and chest ct, etc * no plan of pregnancy and being willing to use effective contraceptive measures (including partner) from informed consent to 6 months after administration of scta01/placebo (abstinence,sterilization operation,contraceptive barrier,acyeterion , etc.)

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: - able to provide written informed consent - males or females. aged ≥ 18 years old - body mass index (bmi) between 18.0 and 26.0 kg/m2 - normal or abnormal but non-clinical significant physical examination, vital signs, 12-ecg and chest ct, etc - no plan of pregnancy and being willing to use effective contraceptive measures (including partner) from informed consent to 6 months after administration of scta01/placebo (abstinence,sterilization operation,contraceptive barrier,acyeterion , etc.)

inclusion criteria: - able to provide written informed consent - males or females. aged ≥ 18 years old - body mass index (bmi) between 18.0 and 26.0 kg/m2 - normal or abnormal but non-clinical significant physical examination, vital signs, 12-ecg and chest ct, etc - no plan of pregnancy and being willing to use effective contraceptive measures (including partner) from informed consent to 6 months after administration of scta01/placebo (abstinence,sterilization operation,contraceptive barrier,acyeterion , etc.)